Interview with Redeye
Magnus Corfitzen, CEO at Ascelia Pharma AB met with Redeye. In this interview, Magnus elaborated on the recent completion of the image reading phase for the SPARKLE Phase 3 re-evaluation study and provided insights into what to expect for the upcoming headline results.